Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.

NCT06724159 · clinicaltrials.gov ↗

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Genitourinary Cancers

Interventions

DRUG: darolutamide
DRUG: Nivolumab monotherapy
DRUG: enfortumab vedotin

Sponsor

Spanish Oncology Genito-Urinary Group

Collaborators

[object Object]